Application of the bacterial outer membrane vesicles in vaccine design

[1]Acevedo R., Fernández S., Zayas C., Acosta A., Sarmiento M.E., Ferro V.A.: Bacterial outer membrane vesicles and vaccine applications. Front. Immunol. 5, DOI: 10.3389/fimmu.2014.00121 (2014)10.3389/fimmu.2014.00121397002924715891Search in Google Scholar

[2]Bai X., Findlow J., Borrow R.: Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles. Expert Opin. Biol. Ther. 11, 969–985 (2011)Search in Google Scholar

[3]Baker J.L., Chen L., Rosenthal J.A., Putnam D., DeLisa M.P.: Microbial biosynthesis of designer outer membrane vesicles. Curr. Opin. Biotechnol. 29, 76–84 (2014)Search in Google Scholar

[4]Bartolini E., Ianni E., Frigimelica E., Petracca R.: Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J. Extracell. Vesicles. 2, DOI: 10.3402/jev.v2i0.20181 (2013)10.3402/jev.v2i0.20181376063724009891Search in Google Scholar

[5]Bauman S.J., Kuehn M.J.: Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. Microbes Infect. 8, 2400–2408 (2006)10.1016/j.micinf.2006.05.001352549416807039Search in Google Scholar

[6]Baumgarten T., Sperling S., Seifert J., von Bergen M., Steiniger F., Wick L., Heipieper H.: Membrane vesicle formation as a multiple-stress response mechanism enhances Pseudomonas putida DOT-T1E cell surface hydrophobicity and biofilm formation. Appl. Environ. Microbiol. 78, 6217–6224 (2012)10.1128/AEM.01525-12341662122752175Search in Google Scholar

[7]Beveridge T.J.: Structures of Gram-negative cell walls and their derived membrane vesicles. J. Bacteriol. 181, 4725–4733 (1999)10.1128/JB.181.16.4725-4733.19999395410438737Search in Google Scholar

[8]Bomberger J.M., MacEachran D.P., Coutermarsh B.A., Ye S., O’Toole G.A., Stanton B.A.: Long-distance delivery of bacterial virulence factors by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 5, DOI: 10.1371/journal.ppat.1000382 (2009)10.1371/journal.ppat.1000382266102419360133Search in Google Scholar

[9]Brudal E., Lampe E., Reubsaet L., Roos N., Hegna I., Thrane I., Koppang E., Winther-Larsen H.C.: Vaccination with outer membrane vesicles from Francisella noatunensis reduces development of francisellosis in a zebrafish model. Fish Shellfish Immunol. 42, 50–57 (2015)10.1016/j.fsi.2014.10.02525449706Search in Google Scholar

[10]Brudeseth B.E., Wiulsrød R., Fredriksen B.N., Lindmo K., Løkling K.E., Bordevik M.: Status and future perspectives of vaccines for industrialised fin-fish farming. Fish Shellfish Immunol. 35, 1759–1768 (2013)10.1016/j.fsi.2013.05.02923769873Search in Google Scholar

[11]Chatterjee S. N., Chaudhuri K.: Lipopolysaccharides of Vibrio cholerae. Physical and chemical characterization. Biochim. Biophys. Acta, 1639, 65–79 (2003)Search in Google Scholar

[12]Clausen T., Southan C., Ehrmann M.: The HtrA family of proteases: implications for protein composition and cell fate. Mol. Cell. 10, 443–455 (2002)Search in Google Scholar

[13]Collins B.S.: Gram-negative outer membrane vesicles in vaccine development. Discov. Med. 12, 7–15 (2011)Search in Google Scholar

[14]Daczkowska-Kozon E.: Kampylobakterioza – możliwe źródła infekcji. Folia Univ. Agric. Stetin. Scientia Alimentaria, 238, 21–28 (2004)Search in Google Scholar

[15]De S.N.: Enterotoxicity of bacteria-free culture-filtrate of Vibrio cholerae. Nature, 183, 1533–1534 (1959)10.1038/1831533a013666809Search in Google Scholar

[16]Deatherage B.L., Lara J.C., Bergsbaken T., Rassoulian Barrett S.L., Lara S., Cookson B.T.: Biogenesis of bacterial membrane vesicles. Mol. Microbiol. 72, 1395–1407 (2009)Search in Google Scholar

[17]Delbos V., Lemée L., Bénichou J., Berthelot G., Deghmane A.E., Leroy J.P., Houivet E., Hong E., Taha M.K., Caron F.: Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage. Vaccine, 31, 4416–4420 (2013)10.1016/j.vaccine.2013.06.08023856330Search in Google Scholar

[18]Ellen A.F., Albers S.V., Huibers W., Pitcher A., Hobel C.F., Schwarz H., Folea M., Schouten S., Boekema E.J., Poolman B.: Proteomic analysis of secreted membrane vesicles of archaeal Sulfolobus species reveals the presence of endosome sorting complex components. Extremophiles, 13, 67–79 (2009)10.1007/s00792-008-0199-xSearch in Google Scholar

[19]Elmi A., Dorrell N. i wsp.: Campylobacter jejuni outer membrane vesicles play an important role in bacterial interactions with human intestinal epithelial cells. Infect. Immun. 80, 4089–4098 (2012)Search in Google Scholar

[20]Fernández S., Fajardo E.M., Mandiarote A., Año G., Padrón M.A., Acosta M.: A proteoliposome formulation derived from Bordetella pertussis induces protection in two murine challenge models. BMC Immunol. 14, DOI: 10.1186/1471-2172-14-S1-S8 (2013)10.1186/1471-2172-14-S1-S8Search in Google Scholar

[21]Finco O., Frigimelica E., Buricchi F., Petracca R., Galli G.: Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc. Natl. Acad. Sci. USA, 108, 9969–9974 (2011)10.1073/pnas.1101756108Search in Google Scholar

[22]Finne J., Leinonen M., Makela P.H.: Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet, 2, 355–357 (1983)10.1016/S0140-6736(83)90340-9Search in Google Scholar

[23]Furuta N., Tsuda K., Omori H., Yoshimori T., Yoshimura F., Amano A.: Porphyromonas gingivalis outer membrane vesicles enter human epithelial cells via an endocytic pathway and are sorted to lysosomal compartments. Infect. Immun. 77, 4187– 4196 (2009)Search in Google Scholar

[24]Główny Inspektorat Sanitarny: Stan sanitarny kraju w roku 2014, http://gis.gov.pl/images/kafelki/stan_sanitarny_kraju.pdf (06.09.2016)Search in Google Scholar

[25]Gurung M., Moon D.C., Choi C.W., Lee J.H., Bae Y.C., Kim J., Lee Y.C., Seol S.Y., Cho D.T., Kim S.I.: Staphylococcus aureus produces membrane-derived vesicles that induce host cell death. PloS One, 6, DOI: 10.1371/journal.pone.0027958 (2011)10.1371/journal.pone.0027958321807322114730Search in Google Scholar

[26]Helms M., Simonsen J., Olsen K.E., Mølbak K.: Adverse health events associated with antimicrobial drug resistance in Campylobacter species: a registry-based cohort study. J. Infect. Dis. 191, 1050–1055 (2005)Search in Google Scholar

[27]Holst J.D., Martin R., Campa C., Oster P., O’Hallahan J., Rosenqvist E.: Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis. Vaccine, 27, DOI: 10.1016/j.vaccine.2009.04.071 (2009)10.1016/j.vaccine.2009.04.07119481313Search in Google Scholar

[28]Huang W., Yao Y., Long Q., Yang X., Sun W.: Immunization against multidrug-resistant Acinetobacter baumannii effectively protects mice in both pneumonia and sepsis models. PLoS One, 9, DOI: 10.1371/journal.pone.0100727 (2014)10.1371/journal.pone.0100727406735424956279Search in Google Scholar

[29]Huntley J.F., Conley P.G., Hagman K.E., Norgard M.V.: Characterization of Francisella tularensis outer mambrane proteins. J. Bacteriol. 189, 561–574 (2007)10.1128/JB.01505-06179740117114266Search in Google Scholar

[30]Jagusztyn-Krynicka E.K., Łaniewski P., Wyszyńska A.: Update on Campylobacter jejuni vaccine development for preventing human campylobacteriosis. Expert. Rev. Vaccines, 8, 625–645 (2009)Search in Google Scholar

[31]Jang K.S., Sweredoski M.J., Graham R.L., Hess S., Clemons W.M.: Comprehensive proteomic profiling of outer membrane vesicles from Campylobacter jejuni. J. Proteomics, 98, 90–98 (2014)10.1016/j.jprot.2013.12.014453400324382552Search in Google Scholar

[32]Jun S.H., Lee J.H., Kim B.R., Kim S.I., Park T.I., Lee J.C., Lee Y.C.: Acinetobacter baumannii outer membrane vesicles elicit a potent innate immune response via membrane proteins. PLoS One, 8, DOI: 10.1371/journal.pone.0071751 (2013)10.1371/journal.pone.0071751374374423977136Search in Google Scholar

[33]Kaaijk P., van Straaten I., van de Waterbeemd B., Boot E.P., Levels L.M., van Dijken H.H., van den Dobbelsteen G.P.: Preclinical safety and immunogenicity evaluation of a nonavalent PorA native outer membrane vesicle vaccine against serogroup B meningococcal disease. Vaccine, 31, 1065–1071 (2013)10.1016/j.vaccine.2012.12.03123273968Search in Google Scholar

[34]Kadurugamuwa J.L., Beveridge T.J.: Membrane vesicles derived from Pseudomonas aeruginosa and Shigella flexneri can be integrated into the surfaces of other Gram-negative bacteria. Microbiology, 145, 2051–2060 (1999)10.1099/13500872-145-8-205110463171Search in Google Scholar

[35]Kadurugamuwa J.L., Beveridge, T.J.: Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion. J. Bacteriol. 177, 3998–4008 (1995)10.1128/jb.177.14.3998-4008.19951771307608073Search in Google Scholar

[36]Kahn M.E., Maul G., Goodgal S.H.: Possible mechanism for donor DNA binding and transport in Haemophilus. Proc. Natl. Acad. Sci. USA, 79, 6370–6374 (1982)10.1073/pnas.79.20.63703471236959125Search in Google Scholar

[37]Kitagawa R., Takaya A., Ohya M., Mizunoe Y., Takade A., Yoshida S., Isogai E., Yamamoto T.: Biogenesis of Salmonella enterica serovar Typhimurium membrane vesicles provoked by induction of PagC. J. Bacteriol. 192, 5645–5656 (2010)10.1128/JB.00590-10295367820802043Search in Google Scholar

[38]Klose K.: Regulation of virulence in Vibrio cholerae. Int. J. Med. Microbiol. 29, 81–88 (2001)10.1078/1438-4221-0010411437342Search in Google Scholar

[39]Kłapeć T., Cholewa A.: Tularemia – wciąż groźna zoonoza. Medycyna Ogólna i Nauki o Zdrowiu, 17, 155–160 (2011)Search in Google Scholar

[40]Knox K.W., Vesk M., Work E.: Relation between excreted lipopolysaccharide complexesand surface structures of a lysine limited culture of Escherichia coli. J. Bacteriol. 92, 1206–1217 (1966)10.1128/jb.92.4.1206-1217.19662763964959044Search in Google Scholar

[41]Kulp A., Kuehn M.J.: Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 64, 163–184 (2010)10.1146/annurev.micro.091208.073413352546920825345Search in Google Scholar

[42]Lee E.Y., Bang J.Y., Park G.W., Choi D.S., Kang J.S.: Global proteomic profiling of native outermembrane vesicles derived from Escherichia coli. Proteomics, 7, 3143–3153 (2007)10.1002/pmic.20070019617787032Search in Google Scholar

[43]Locht C.: A common vaccination strategy to solve unsolved problems of tuberculosis and pertussis? Microbes Infect. 10, 1051–1056 (2008)10.1016/j.micinf.2008.07.00818672086Search in Google Scholar

[44]Manning A.J., Kuehn M.J.: Contribution of bacterial outer membrane vesicles to innate bacterial defense. BMC Microbiol. 11, DOI: 10.1186/1471-2180-11-258 (2011)10.1186/1471-2180-11-258324837722133164Search in Google Scholar

[45]Manning A.J., Kuehn M.J.: Functional advantages conferred by extracellular prokaryotic membrane vesicles. J. Mol. Microbiol. Biotechnol. 23, 131–141 (2013)Search in Google Scholar

[46]Mashburn L.M., Whiteley M.: Membrane vesicles traffic signals and facilitate group activities in a prokaryote. Nature, 437, 422–425 (2005)10.1038/nature0392516163359Search in Google Scholar

[47]McBroom A.J., Kuehn M.J.: Release of outer membrane vesicles by Gram-negative bacteria is a novel envelope stress response. Mol. Microbiol. 63, 545–558 (2007)Search in Google Scholar

[48]Mitra S., Chakrabarti M.K., Koley H.: Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis. Vaccine, 31, 3163–3173 (2013)10.1016/j.vaccine.2013.05.00123684822Search in Google Scholar

[49]Nieves W., Asakrah S., Qazi O., Brown K.A., Kurtz J.: A naturally derived outer membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection. Vaccine, 29, 8381–8389 (2011)10.1016/j.vaccine.2011.08.058319586821871517Search in Google Scholar

[50]Nieves W., Petersen H., Judy B.M., Blumentritt C.A., Russell-Lodrigue K., Roy C.J., Torres A.G., Morici L.A.: A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis. Clin. Vaccine Immunol. 21, 747–754 (2014)10.1128/CVI.00119-14401889224671550Search in Google Scholar

[51]Norheim G., Tunheim G., Naess L.M., Bolstad K., Fjeldheim A.K., Garcia L.: A trivalent outer membrane vesicle (OMV) vaccine against serogroup A, W-135 and X meningococcal disease. XVIIIth International Pathogenic Neisseria Conference. Würzburg: Conventus Congress Management & Marketing GmbH (2012)10.1111/j.1365-3083.2012.02709.x22537024Search in Google Scholar

[52]Panatto D., Amicizia D., Lai P.L., Cristina M.L., Domnich A., Gasparini R.: New versus old meningococcal Group B vaccines: How the new ones may benefit infants & toddlers. Indian J. Med. Res. 138, 835–846 (2013)Search in Google Scholar

[53]Pawlikowska M., Deptuła W.: Swoista odporność humoralna a chlamydie i chlamydofile. Post. Hig. Med. Dosw. 15, 505–511 (2006)Search in Google Scholar

[54]Perez J.L., Acevedo R., Callico A., Fernandez Y., Cedre B., Ano G.: A proteoliposome based formulation administered by the nasal route produces vibriocidal antibodies against El Tor Ogawa Vibrio cholerae O1 in BALB/c mice. Vaccine, 27, 205–212 (2009)10.1016/j.vaccine.2008.10.05218996426Search in Google Scholar

[55]Pizza M., Scarlato V., Masignani V.: Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science, 287, 1816–1820 (2000)10.1126/science.287.5459.181610710308Search in Google Scholar

[56]Rachel R., Wyschkony I., Riehl S., Huber H.: The ultrastructure of Ignicoccus: evidence for a novel outer membrane and for intracellular vesicle budding in an archaeon. Archaea, 1, 9–18 (2002)10.1155/2002/307480268554715803654Search in Google Scholar

[57]Ram P.K., Crump J.A., Gupta S.K., Miller M.A., Mintz E.D.: Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984–2005. Epidemiol. Infect. 136, 577–603 (2008)Search in Google Scholar

[58]Renelli M., Matias V., Lo R.Y., Beveridge T.J.: DNA containing membrane vesicles of Pseudomonas aeruginosa PAO1 and their genetic transformation potential. Microbiology, 150, 2161–2169 (2004)10.1099/mic.0.26841-015256559Search in Google Scholar

[59]Rivera J., Cordero R.J., Nakouzi A.S., Frases S., Nicola A., Casadevall A.: Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins. Proc. Natl. Acad. Sci. USA, 107, 19002–19007 (2010)10.1073/pnas.1008843107297386020956325Search in Google Scholar

[60]Rosenthal J.A., Chen L., Baker J.L., Putnam D., DeLisa M.P.: Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale. Curr. Opin. Biotechnol. 28, 51–8 (2014)10.1016/j.copbio.2013.11.00524832075Search in Google Scholar

[61]Rupali J., Danziger L.H.: Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians. Ann. Pharmacother. 38, 1449–1459 (2004)10.1345/aph.1D59215280512Search in Google Scholar

[62]Sack D.A., Sack R.B., Chaignat C.L.: Getting serious about cholera. N. Engl. J. Med. 355, 649–651 (2006)Search in Google Scholar

[63]Schaar V., Nordstrom T., Morgelin M., Riesbeck K.: Moraxella catarrhalis outer membrane vesicles carry β-lactamase and promote survival of Streptococcus pneumoniae and Haemophilus influenzae by inactivating amoxicillin. Antimicrob. Agents Chemother. 55, 3845–3853 (2011)10.1128/AAC.01772-10314765021576428Search in Google Scholar

[64]Schild S., Nelson E.J., Camilli A.: Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect. Immun. 76, 4554–4563 (2008)Search in Google Scholar

[65]Schooling S.R., Hubley A., Beveridge T.J.: Interactions of DNA with biofilm-derived membrane vesicles. J. Bacteriol. 191, 4097–4102 (2009)10.1128/JB.00717-08269848519429627Search in Google Scholar

[66]Segal S., Pollard A.J.: Vaccines against bacterial meningitis. Br. Med. Bull. 72, 65–81 (2005)Search in Google Scholar

[67]Serruto D., Bottomley M.J., Ram S.: The new multicomponent vaccine against meningococcal serogroup B, Bexsero®: immunological, functional and structural characterization of the antigens. Vaccine, 30, 87–97 (2012)10.1016/j.vaccine.2012.01.033336087722607904Search in Google Scholar

[68]Sierra G., Campa H.C., Varcacel N.M., Izquierdo P.L., Sotolongo P.F., Garcia L.: Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba. NIPH Ann. 14, 195–210 (1991)Search in Google Scholar

[69]Silva E.B., Dow S.W.: Development of Burkholderia mallei and Pseudomallei vaccines. Front. Cell. Infect. Microbiol. 3, DOI: 10.3389/fcimb.2013.00010 (2013)10.3389/fcimb.2013.00010359800623508691Search in Google Scholar

[70]Silva J., Leite D., Fernandes M.: Campylobacter spp. as a foodborne pathogen: A Review. Front. Microbiol. 2, DOI: 10.3389/fmicb.2011.00200 (2011)10.3389/fmicb.2011.00200318064321991264Search in Google Scholar

[71]Sinha R., Koley H., Nag D., Mitra S., Mukhopadhyay A.K., Chattopadhyay B.: Pentavalent outer membrane vesicles of Vibrio cholerae induce adaptive immune response and protective efficacy in both adult and passive suckling mice models. Microbes Infect. 17, 215–227 (2015)10.1016/j.micinf.2014.10.01125461799Search in Google Scholar

[72]Sinha S., Langford P., Kroll J.: Functional diversity of three different DsbA proteins from Neisseria meningitidis. Microbiology, 150, 2993–3000 (2004)10.1099/mic.0.27216-015347757Search in Google Scholar

[73]Tan L.K., Carlone G.M., Borrow R.: Advances in the development of vaccines against Neisseria meningitidis. N. Engl. J. Med. 362, 1511–1520 (2010)Search in Google Scholar

[74]Tribble D.R., Baqar S., Carmolli M.P., Porter C.: Campylobacter jejuni strain CG8421: a refined model for the study of Campylobacteriosis and evaluation of Campylobacter vaccines in human subjects. Clin. Infect. Dis. 49, 1512–1519 (2009)Search in Google Scholar

[75]Unal C.M., Schaar V., Riesbeck K.: Bacterial outer membrane vesicles in disease and preventive medicine. Semin. Immunopathol. 33, 395–408 (2011)10.1007/s00281-010-0231-y21153593Search in Google Scholar

[76]van de Waterbeemd B., Streefland M., van der Ley P., Zomer B., van Dijken H.: Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process. Vaccine, 28, 4810–4816 (2010)10.1016/j.vaccine.2010.04.08220483197Search in Google Scholar

[77]van der Ley P., Steeghs L., Hamstra H.J.: Modification of lipid A biosynthesis in Neisseria meningitidis lpxL mutants: influence on lipopolysaccharide structure, toxicity, and adjuvant activity. Infect. Immun. 69, 5981–5990 (2001)10.1128/IAI.69.10.5981-5990.20019872511553534Search in Google Scholar

[78]Von Seidlein L., Kim D.R., Ali M., Lee H., Wang X.: A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Med. 3, DOI: 10.1371/journal.pmed.0030353 (2006)10.1371/journal.pmed.0030353156417416968124Search in Google Scholar

[79]Wiersinga W.J., Currie B.J., Peacock S.J.: Melioidosis. N. Engl. J. Med. 367, 1035–1044 (2012)Search in Google Scholar

[80]Wyle F.A., Artenstein M.S., Brandt B.L.: Immunologic response of man to group B meningococcal polysaccharide vaccines. J. Infect. Dis. 126, 514–521 (1972)Search in Google Scholar

[81]Yaron S., Kolling G.L., Simon L., Matthews K.R.: Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria. Appl. Environ. Microbiol. 66, 4414–4420 (2000)Search in Google Scholar

[82]Yonezawa H., Osaki T., Kurata S., Fukuda M., Kawakami H., Ochiai K., Hanawa T., Kamiya S.: Outer membrane vesicles of Helicobacter pylori TK1402 are involved in biofilm formation. BMC Microbiol. 9, DOI: 10.1186/1471-2180-9-197 (2009)10.1186/1471-2180-9-197274905519751530Search in Google Scholar

[83]Young K.T., Davis L.M., Dirita V.J.: Campylobacter jejuni: molecular biology and pathogenesis. Nat. Rev. Microbiol. 5, 665–679 (2007)Search in Google Scholar

[84]Zhou L., Srisatjaluk R., Justus D.E., Doyle R.J.: On the origin of membrane vesicles in Gram-negative bacteria. FEMS Microbiol. Lett. 163, 223–228 (1998)Search in Google Scholar